CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM

Riik: Kanada

keel: inglise

Allikas: Health Canada

Toimeaine:

CLOTRIMAZOLE

Saadav alates:

TARO PHARMACEUTICALS INC

ATC kood:

G01AF02

INN (Rahvusvaheline Nimetus):

CLOTRIMAZOLE

Annus:

2%

Ravimvorm:

CREAM

Koostis:

CLOTRIMAZOLE 2%

Manustamisviis:

VAGINAL

Ühikuid pakis:

15G/50G

Retsepti tüüp:

OTC

Terapeutiline ala:

AZOLES

Toote kokkuvõte:

Active ingredient group (AIG) number: 0110231003; AHFS:

Volitamisolek:

APPROVED

Loa andmise kuupäev:

2020-08-18

Toote omadused

_ _
_CLOTRIMAZOLE VAGINAL 6 _
_CLOTRIMAZOLE VAGINAL 3 _
_CLOTRIMAZOLE EXTERNAL CREAM _
_CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM _
_CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM _
_ PAGE 1 OF 29 _
PRODUCT MONOGRAPH
CLOTRIMAZOLE VAGINAL 6
(Clotrimazole Vaginal Cream USP 1%)
CLOTRIMAZOLE VAGINAL 3
(Clotrimazole Vaginal Cream USP 2%)
CLOTRIMAZOLE EXTERNAL CREAM
(Clotrimazole
Cream USP 1%) CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM
(Clotrimazole
Cream USP 1%)
CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL
CREAM
(Clotrimazole
Cream USP 2%)
ANTIFUNGAL AGENT
Taro Pharmaceuticals
Inc.
Date of Revision:
130 East Drive
April 29, 2022
Brampton, Ontario
L6T 1C1
Control # 263251
_ _
_CLOTRIMAZOLE VAGINAL 6 _
_CLOTRIMAZOLE VAGINAL 3 _
_CLOTRIMAZOLE EXTERNAL CREAM _
_CLOTRIMAZOLE EXTERNAL ANTIFUNGAL CREAM _
_CLOTRIMAZOLE EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM _
_ PAGE 2 OF 29 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................................
3
SUMMARY
PRODUCT
INFORMATION
............................................................................................
3
INDICATIONS
AND
CLINICAL
USE..................................................................................................
3
CONTRAINDICATIONS
.....................................................................................................................
4
WARNINGS
AND
PRECAUTIONS
.....................................................................................................
4
ADVERSE
REACTIONS
.....................................................................................................................
5
DRUG
INTERACTIONS
......................................................................................................................
6
DOSAGE
AND
ADMINISTRATION
...................................................................................................
6
OVERDOSAGE
...................................................................................................